Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | HCM | VCEL | ||
| Company | Dicerna Pharmaceutic | Hutchmed China Ltd ADR | Vericel Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 17.43 | 56.70 | ||
| High | 38.24 | 17.60 | 60.15 | ||
| Low | 38.21 | 17.27 | 56.51 | ||
| Last | 38.22 | 17.36 | 59.11 | ||
| Change | +0.22 | -0.32 | +2.40 | ||
| % Change | +0.58% | -1.81% | +4.23% | ||
| Volume | 5,568,900 | 26,000 | 603,400 | ||
| 20-Day Average Volume | 3,647,665 | 76,160 | 455,655 | ||
| Previous Close | 38.00 | 17.68 | 56.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 18.01 | 51.07 | ||
| 20-Day Raw Stochastic | 90.72% | 18.27% | 93.71% | ||
| 20-Day Relative Strength | 80.40% | 44.00% | 70.47% | ||
| Weighted Alpha | +35.17 | -8.26 | +64.27 | ||
| Today's Opinion | 88% Buy | 24% Sell | 56% Buy | ||
| Previous Opinion | 72% Buy | 24% Sell | 56% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | +3.70% since 11/15/24 | +12.63% since 11/15/24 | ||
| Low | 37.81 on 12/21/21 | 16.58 on 11/19/24 | 51.53 on 11/18/24 | ||
| High | 38.24 on 12/27/21 | 18.44 on 11/20/24 | 60.15 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | -18.42% since 10/22/24 | +41.31% since 10/22/24 | ||
| Low | 37.78 on 12/10/21 | 16.58 on 11/19/24 | 41.34 on 10/23/24 | ||
| High | 38.26 on 12/03/21 | 21.50 on 10/23/24 | 60.15 on 11/22/24 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | -2.96% since 08/22/24 | +24.44% since 08/22/24 | ||
| Low | 19.06 on 10/06/21 | 15.82 on 09/10/24 | 39.12 on 10/10/24 | ||
| High | 38.26 on 12/03/21 | 21.50 on 10/23/24 | 60.15 on 11/22/24 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | -11.79% since 05/22/24 | +17.44% since 05/22/24 | ||
| Low | 19.06 on 10/06/21 | 15.82 on 09/10/24 | 39.12 on 10/10/24 | ||
| High | 40.14 on 07/20/21 | 21.50 on 10/23/24 | 60.15 on 11/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,026,056 | 2,917,552 | ||
| Shares Outstanding, K | 78,129 | 174,312 | 49,358 | ||
| Annual Sales | 164,310,000 | 838,000,000 | 197,520,000 | ||
| Annual Net Income | -112,750,000 | 100,780,000 | -3,180,000 | ||
| Last Quarter Sales | 62,950,000 | 75,806,000 | 57,910,000 | ||
| Last Quarter Net Income | -17,070,000 | -61,254,000 | -900,000 | ||
| 60-Month Beta | 0.80 | 0.85 | 1.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | N/A on 07/28/21 | -0.02 on 11/07/24 | ||
| Latest Earnings Date | 11/09/21 | 07/31/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 945.17 | ||